Tower Research Capital (TRC)’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio LOAC Stock Details LOAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-400	Closed	-$5K	–	6013
2020 Q4	$5K	Buy	+400	New	+$4.39K	﹤0.01%	4680

Tower Research Capital (TRC)'s LOAC Position: Q1 2021 in Review

Tower Research Capital (TRC) sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q1 2021, closing a stake of 400 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in LOAC in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 0 funds tracked by Wall St. Rank hold LOAC as of Q1 2021.

Tower Research Capital (TRC) reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 400 Longevity Acquisition Corporation Ordinary Shares shares in Q1 2021, an estimated $5K.
Tower Research Capital (TRC) first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2020 and held it in 1 quarter.
Tower Research Capital (TRC)'s Longevity Acquisition Corporation Ordinary Shares position peaked at $5K in Q4 2020.
0 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q1 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.